WALTHAM, Mass., Oct. 22, 2024 (GLOBE NEWSWIRE) — Apellis Pharmaceuticals (NASDAQ:)Inc. (Nasdaq: APLS) today announced that the company will host a conference call and webcast on Tuesday, November 5, 2024, at 8:30 a.m. EST to discuss its third quarter 2024 financial results.
To access the live call over the phone, you must register for the call in advance Here. A live audio webcast of the event and accompanying slides can also be accessed via the Events & Presentations page in the Investors & Media section of the company’s website. A replay of the webcast will be available for 90 days from the event.
About Apellis
Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that combines bold science and compassion to develop life-changing therapies for some of the most challenging diseases facing patients. We introduced the first new class of complement drugs in 15 years and now have two approved C3-targeted drugs. These include the first-ever treatment for geographic atrophy, the leading cause of blindness worldwide. We believe we have only just begun to unlock the potential of targeting C3 for serious retinal, rare and neurological diseases. For more information, visit http://apellis.com or follow us on Twitter and LinkedIn.
Investor contact:
Meredith (NYSE:) Kaya
meredith.kaya@apellis.com
617.599.8178
